US Stocks
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc (FDMT)








Key Stats

Today Low/High
$31.74 / $32.31
52 Week Low/High
$21.4 / $55.11
Market Cap

Company Details

4DMT is a clinical-stage company harnessing the power of directed evolution for targeted gene therapies. 4DMT seeks to unlock the full potential of gene therapy using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately one billion synthetic capsid sequences to invent evolved vectors for use in targeted gene therapy products. The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The 4DMT targeted and evolved vectors are invented with the goal of being delivered through clinically routine, well-tolerated and minimally invasive routes of administration, transducing diseased cells in target tissues efficiently, having reduced immunogenicity and, where relevant, having resistance to pre-existing antibodies. 4DMT is currently conducting three clinical trials: 4D-125 is in a Phase 1/2 clinical trial for XLRP patients, 4D-110 is in a Phase 1 clinical trial for choroideremia patients and 4D-310 is in a Phase 1/2 clinical trial for Fabry disease patients. 4D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT.
4D Molecular Therapeutics Inc

Discover more

Frequently Asked Questions

What is 4D Molecular Therapeutics Inc (FDMT) share price today?

Can Indians buy 4D Molecular Therapeutics Inc (FDMT) shares?

How can I buy 4D Molecular Therapeutics Inc (FDMT) shares from India?

Can Fractional shares of 4D Molecular Therapeutics Inc (FDMT) be purchased?

What are the documents required to start investing in 4D Molecular Therapeutics Inc (FDMT) stocks?

We are a SEBI registered investement advisor